{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:42:28Z","timestamp":1791085348353,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jsb.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T17:34:36Z","timestamp":1364405676000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and\/or therapy"],"prefix":"10.1016","volume":"185","author":[{"given":"E.","family":"Eggenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsb.2013.03.009_b0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2967\/jnumed.108.056929","article-title":"Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine","volume":"50","author":"Ahlgren","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jsb.2013.03.009_b0010","series-title":"Lipocalins","author":"\u00c5kerstr\u00f6m","year":"2006"},{"key":"10.1016\/j.jsb.2013.03.009_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.nucmedbio.2007.04.001","article-title":"Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view","volume":"34","author":"Boswell","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbapap.2005.12.006","article-title":"Comparative ligand-binding analysis of ten human lipocalins","volume":"1764","author":"Breustedt","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsb.2013.03.009_b0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0076-6879(97)77021-6","article-title":"Free R value: cross-validation in crystallography","volume":"277","author":"Brunger","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jsb.2013.03.009_b0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jsb.2013.03.009_b0035","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/ja029363k","article-title":"A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series","volume":"125","author":"Corneillie","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jsb.2013.03.009_b0040","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.jsb.2013.03.009_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.271.5246.163","article-title":"Cation-\u03c0 interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp","volume":"271","author":"Dougherty","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jsb.2013.03.009_b0050","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jsb.2013.03.009_b0055","series-title":"Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding","author":"Fersht","year":"1998"},{"key":"10.1016\/j.jsb.2013.03.009_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0003-2697(86)90228-9","article-title":"Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea","volume":"155","author":"Fling","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsb.2013.03.009_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3180001","article-title":"The lipocalin protein family: structure and function","volume":"318","author":"Flower","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsb.2013.03.009_b0070","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1242\/jcs.086850","article-title":"Positive charges on the translocating polypeptide chain arrest movement through the translocon","volume":"124","author":"Fujita","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jsb.2013.03.009_b0075","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: The proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsb.2013.03.009_b0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cbpa.2009.04.627","article-title":"Engineered protein scaffolds as next-generation antibody therapeutics","volume":"13","author":"Gebauer","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-396962-0.00007-0","article-title":"Anticalins: small engineered binding proteins based on the lipocalin scaffold","volume":"503","author":"Gebauer","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jsb.2013.03.009_b0090","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jmb.2012.12.004","article-title":"Combinatorial design of an Anticalin directed against the extra-domain B for the specific targeting of oncofetal fibronectin","volume":"425","author":"Gebauer","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jsb.2013.03.009_b0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1200\/JCO.2005.03.8471","article-title":"Antibody pretargeting advances cancer radioimmunodetection and radioimmuno-therapy","volume":"24","author":"Goldenberg","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsb.2013.03.009_b0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/thno.3582","article-title":"Pretargeted molecular imaging and radioimmunotherapy","volume":"2","author":"Goldenberg","year":"2012","journal-title":"Theranostics"},{"key":"10.1016\/j.jsb.2013.03.009_b0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jsb.2013.03.009_b0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2013.03.009_b0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ab.2006.01.034","article-title":"Kinetic analysis of a high-affinity antibody\/antigen interaction performed by multiple Biacore users","volume":"352","author":"Katsamba","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsb.2013.03.009_b0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2011.10.017","article-title":"Recent trends in antibody-based oncologic imaging","volume":"315","author":"Kaur","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsb.2013.03.009_b0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/17425247.3.1.53","article-title":"Tailoring antibodies for radionuclide delivery","volume":"3","author":"Kenanova","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jsb.2013.03.009_b0135","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1021\/ja806857r","article-title":"High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2","volume":"131","author":"Kim","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jsb.2013.03.009_b0140","series-title":"Protein Engineering and Design","first-page":"109","article-title":"Design and engineering of synthetic binding proteins using nonantibody scaffolds","author":"Koide","year":"2010"},{"key":"10.1016\/j.jsb.2013.03.009_b0145","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0150","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nprot.2008.91","article-title":"Automated macromolecular model building for X-ray crystallography using ARP\/wARP version 7","volume":"3","author":"Langer","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jsb.2013.03.009_b0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck \u2013 a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jsb.2013.03.009_b0160","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.febslet.2010.04.014","article-title":"Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications","volume":"584","author":"L\u00f6fblom","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsb.2013.03.009_b0165","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1021\/bi00092a004","article-title":"How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab\u2019\/hapten complexes with different metals in the chelate","volume":"32","author":"Love","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsb.2013.03.009_b0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jsb.2013.03.009_b0175","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00726-010-0503-9","article-title":"Protein scaffold-based molecular probes for cancer molecular imaging","volume":"41","author":"Miao","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.jsb.2013.03.009_b0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrd1413","article-title":"Antibody-targeted radiation cancer therapy","volume":"3","author":"Milenic","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsb.2013.03.009_b0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","article-title":"Improving biosensor analysis","volume":"12","author":"Myszka","year":"1999","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jsb.2013.03.009_b0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nucmedbio.2010.08.013","article-title":"Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging","volume":"38","author":"Orcutt","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0195","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/pro.45","article-title":"Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn","volume":"18","author":"Pan","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.jsb.2013.03.009_b0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsb.2013.03.009_b0205","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1073\/pnas.0630018100","article-title":"Enterobactin: an archetype for microbial iron transport","volume":"100","author":"Raymond","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsb.2013.03.009_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/mabs.3.1.13895","article-title":"Antibody-based therapeutics to watch in 2011","volume":"3","author":"Reichert","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.jsb.2013.03.009_b0215","first-page":"1201","article-title":"Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein","volume":"46","author":"Sato","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jsb.2013.03.009_b0220","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1515\/BC.2001.166","article-title":"Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold","volume":"382","author":"Schlehuber","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jsb.2013.03.009_b0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0301-4622(02)00026-1","article-title":"Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant \u2013 a so-called \u2018anticalin\u2019 \u2013 using a molecular random approach","volume":"96","author":"Schlehuber","year":"2002","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jsb.2013.03.009_b0230","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1006\/jmbi.2000.3646","article-title":"A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin","volume":"297","author":"Schlehuber","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0235","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/nprot.2007.209","article-title":"The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins","volume":"2","author":"Schmidt","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jsb.2013.03.009_b0240","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1073\/pnas.0813399106","article-title":"An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies","volume":"106","author":"Sch\u00f6nfeld","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsb.2013.03.009_b0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","article-title":"A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions","volume":"19","author":"Shapovalov","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.jsb.2013.03.009_b0250","doi-asserted-by":"crossref","first-page":"7109s","DOI":"10.1158\/1078-0432.CCR-1004-0009","article-title":"Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods","volume":"11","author":"Sharkey","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsb.2013.03.009_b0255","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13277-012-0367-6","article-title":"Pretargeting: taking an alternate route for localizing radionuclides","volume":"33","author":"Sharkey","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0260","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.nucmedbio.2011.05.003","article-title":"Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody","volume":"38","author":"Shin","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jsb.2013.03.009_b0265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0167-4838(00)00145-X","article-title":"Lipocalins as a scaffold","volume":"1482","author":"Skerra","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsb.2013.03.009_b0270","first-page":"336","article-title":"Anticalins as alternative binding proteins for therapeutic use","volume":"9","author":"Skerra","year":"2007","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jsb.2013.03.009_b0275","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.copbio.2007.04.010","article-title":"Alternative non-antibody scaffolds for molecular recognition","volume":"18","author":"Skerra","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jsb.2013.03.009_b0280","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1742-4658.2008.06439.x","article-title":"Alternative binding proteins: anticalins \u2013 harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities","volume":"275","author":"Skerra","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.jsb.2013.03.009_b0285","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-11-0483","article-title":"Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends","volume":"17","author":"Steiner","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsb.2013.03.009_b0290","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-009-1283-x","article-title":"Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount","volume":"37","author":"Tolmachev","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jsb.2013.03.009_b0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/107327481201900304","article-title":"Radioimmunotherapy for B-cell non-hodgkin lymphomas","volume":"19","author":"Tomblyn","year":"2012","journal-title":"Cancer Control"},{"key":"10.1016\/j.jsb.2013.03.009_b0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nbt0396-309","article-title":"Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library","volume":"14","author":"Vaughan","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jsb.2013.03.009_b0305","doi-asserted-by":"crossref","first-page":"W403","DOI":"10.1093\/nar\/gkm263","article-title":"NQ-Flipper: recognition and correction of erroneous asparagine and glutamine side-chain rotamers in protein structures","volume":"35","author":"Weichenberger","year":"2007","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847713000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847713000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T12:20:06Z","timestamp":1562847606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047847713000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1047847713000804"],"URL":"https:\/\/doi.org\/10.1016\/j.jsb.2013.03.009","relation":{},"ISSN":["1047-8477"],"issn-type":[{"value":"1047-8477","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and\/or therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsb.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}